Ruey-ching (Richard) Hwang, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ruey-ching (Richard) Hwang, PhD


Ruey-ching (Richard) Hwang, PhD
Senior Director,
Pharmaceutical Sciences
Pfizer Global R&D

Richard (Ruey-ching) Hwang is senior director of clinical supply manufacturing at Pfizer and has been with the company since 2003. He previously held positions at Pharmacia, Mallinckrodt, and G.D. Searle.

Hwang has authored and/or coauthored nearly 20 papers, given nearly 40 presentations and training courses, and presented more than 20 posters at poster sessions. He is a member of the American Association of Pharmaceutical Scientists (AAPS) and is a member of Pharmaceutical Technology’s Editorial Advisory Board.

He holds an MBA from the Keller Graduate School of Management at DeVry University and a PhD in Pharmaceutics from the College of Pharmacy at the University of Iowa. He received his BS in Pharmacy from the School of Pharmacy, College of Medicine, National Taiwan University.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here